Stock Alert: Bilibili Rises 10%

By RTTNews Staff Write  ✉   | Published:

Shares of Bilibili Inc. (BILI) gained over 10% on Wednesday morning despite no stock-related news to drive the shares. Meanwhile, major U.S. stock indexes opened higher on Wednesday morning, particularly on COVID-19 vaccine optimism.

BILI is currently trading at $92.25, up $9.80 or 11.89%, on the Nasdaq.

Bilibili provides online entertainment services for youth in China. It offers a platform that covers a range of genres and media formats, including videos, live broadcasting, and mobile games.

For comments and feedback contact: editorial@rttnews.com

Business News

Next Story
Editors Pick
Shane Erickson Recalls Wash-Free Hand Sanitizer
Shane Erickson, Inc. has recalled certain Wash-Free Hand Sanitizer due to the potential presence of methanol, i.e., wood alcohol, the U.S. Food and Drug Administration said in a statement. The hand sanitizer was distributed across the country to wholesale and retail customers.
AstraZeneca's COVID-19 Vaccine Authorized In UK
British drug major AstraZeneca Plc.'s COVID-19 vaccine, co-developed by the University of Oxford, has been approved for emergency supply in the UK. The company is releasing the first doses today so that vaccinations may begin early in the New Year. AstraZeneca aims to supply millions of doses in the first quarter as part of an agreement with the government to supply up to 100 million doses.
FDA Nod For First Generic Drug To Treat Severe Hypoglycemia
The U.S. Food and Drug Administration approved the first generic drug to treat severe hypoglycaemia or dangerously low blood sugar levels, which could occur in patients with diabetes mellitus and who are using insulin treatment. Amphastar Pharmaceuticals' glucagon for injection USP, 1 mg/vial, packaged in an emergency kit, is the first-ever FDA approval of a generic version of rDNA Glucagon.